Analyst Ravi Mehrotra is covering the the Healthcare sector with 27 price targets and ratings documented since 2012 spanning on 2 stocks.
Ravi Mehrotra's average stock forecast success ratio is 95% with an average time for price targets to be met of 299.5 days.
Most recent stock forecast was given on BIIB, Biogen Inc at 19-Mar-2015.
Analyst best performing recommendations are on BIIB (BIOGEN INC).
The best stock recommendation documented was for BIIB (BIOGEN INC) at 3/4/2013. The price target of $200 was fulfilled within 56 days with a profit of $43.45 (27.75%) receiving and performance score of 4.96.
Average potential price target upside
Currently, out of the existing stock ratings of Ravi Mehrotra - 14 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
313
2 days ago
18/18 (100%)
$19.32 (6.49%)
241
Buy
321
$12.12 (3.92%)
325
2 days ago
5/14 (35.71%)
$64.65 (25.31%)
224
Buy
340
$31.12 (10.08%)
340
3 days ago
13/17 (76.47%)
$25.22 (9.40%)
201
Buy
340
$31.12 (10.08%)
350
8 days ago
35/45 (77.78%)
$28.45 (10.91%)
150
Buy
360
$51.12 (16.55%)
346
9 days ago
37/49 (75.51%)
$56 (19.33%)
464
